Paul Jolivet is a member of the Paris Bar. He advises French and international clients, including industrial companies, investment funds and institutional investors, on M&A and Private Equity transactions.
Prior to joining Jeantet, Paul practiced in law firms specializing in Mergers & Acquisitions and Private Equity.
Skills
Lawyer since : 2022
Bar. : Paris
Language(s) : French - English
Training :
- Master II Juriste d’Affaires Internationales – Université de Rennes I
- Master Droit & Management – ESCP Business School
Jeantet advises investment funds Orbimed and MorningSide Ventures in connection with €39 million financing of Enyo Pharma
Paris, January 8, 2024 – Jeantet advised investment funds OrbiMed and Morningside Ventures in connection with the Series C financing of French biopharmaceutical company ENYO Pharma. ENYO Pharma, a clinical-stage biopharmaceutical company developing proprietary medicines to improve quality of life and avoid end-stage renal failure and dialysis in patients with kidney disease, announced on January […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises investment funds Orbimed and Jeito Capital in connection with a EUR 65 million financing of Corteria Pharmaceuticals
Paris, September 8, 2023 – Jeantet has advised investment funds OrbiMed and Jeito Capital in connection with the series A financing of French biopharmaceutical company Corteria Pharmceuticals. Corteria Pharmaceuticals, a biopharmaceutical company specializing in the development of transformative therapies for heart failure subpopulations, announced on September 7, 2023 a EUR 65 million series A financing, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises Turenne in connection with an owner by out (OBO) in the capital of Vitalis
Paris, May 17, 2023, Jeantet has advised Turenne, an independent private equity firm, on an owner by out (OBO) in the capital of Vitalis, the family-owned group based in the north of France and the number one independent packer and trader of potatoes and fresh seasonings. The family-owned Vitalis Group, with revenues estimated at €150 […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | EMPLOYMENT
Jeantet advises Agrofert on the acquisition of Borealis’ nitrogen production business.
Paris, June 7, 2022 – Jeantet and the Austrian law firm Wolf Theiss have advised the Agrofert group, a European leader in the production of nitrogen fertilizers, on the acquisition of Borealis’ nitrogen production business, which includes fertilizers, melamine and technical nitrogen. The offer values Borealis’ “nitrogen” business on an enterprise value basis of EUR […]
Paris, Franco-German team | CORPORATE – M&A – PRIVATE EQUITY | EMPLOYMENT | BANK-FINANCE-REGULATORY | IP, TECH & DATA | REAL ESTATE | COMPETITION AND ECONOMIC LAW | PUBLIC LAW – PUBLIC CONTRACTS
Jeantet advises Getinge on the contemplated acquisition of Fluoptics, a leader in fluorescence imaging as an aid to surgery
Paris, 3 May 2022 – Jeantet has advised the Swedish listed global medical technology company Getinge AB (publ), with respect to the contemplated acquisition via its French subsidiary Getinge Infection Control SAS of 100% of the shares and voting rights of Fluoptics SAS a leader in fluorescence imaging as an aid to surgery. The transaction […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | IP, TECH & DATA | FINANCING | REAL ESTATE
Jeantet advises Thinkproject on its acquisition of Kairnial Group, a market leader in the field of digital solutions in construction
Munich/ Paris, 17 January 2022 – Jeantet advised Thinkproject, a portfolio company of the global investment organization EQT, on its acquisition of Kairnial Group and its subsidiaries, from the Pélican Venture and the management of Kairnial Group. With this transaction, Thinkproject and French market leader Kairnial Group combine their offering to deliver cutting edge common data […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | TAX | IP, TECH & DATA | BANK-FINANCE-REGULATORY | EMPLOYMENT
Jeantet advises Vertiv (NYSE: VRT) on the sale of its french subsidiary, Vertiv Industrial Systems, and the foreigne assets of its industrial business in the United Kingdom, Turkey, Spain and theUunited Arab Emirates
Paris, 10 January 2022 – Jeantet advised Vertiv, a company listed on the New York Stock Exchange (NYSE), on the sale of its French subsidiary Vertiv Industrial Systems (now Chloride) and the foreign assets of its industrial activities in the United Kingdom, Turkey, Spain and the United Arab Emirates, forming the Chloride group, to Innovafonds […]
| CORPORATE – M&A – PRIVATE EQUITY | IP, TECH & DATA